Version 5.4
Mus musculus Protein: Slc13a2
Summary
InnateDB Protein IDBP-202824.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Slc13a2
Protein Name solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2
Synonyms mNaDC-1; Nadc1;
Species Mus musculus
Ensembl Protein ENSMUSP00000001122
InnateDB Gene IDBG-202822 (Slc13a2)
Protein Structure
UniProt Annotation
Function Cotransport of sodium ions and dicarboxylates such as succinate and citrate.
Subcellular Localization Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
Disease Associations
Tissue Specificity Highly expressed in kidney and small intestine. Not detectable in brain, heart, stomach and skeletal muscle.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0005215 transporter activity
GO:0015293 symporter activity
Biological Process
GO:0006814 sodium ion transport
GO:0055085 transmembrane transport
Cellular Component
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID MGI:1276558
InterPro IPR001898 Sodium/sulphate symporter
IPR004680 Citrate transporter-like domain
PFAM PF00939
PF03600
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q9ES88
PhosphoSite PhosphoSite-Q9ES88
TrEMBL
UniProt Splice Variant
Entrez Gene 20500
UniGene Mm.274058
RefSeq NP_071856
MGI ID
MGI Symbol Slc13a2
OMIM
CCDS CCDS25103
HPRD
IMGT
EMBL AF201903 BC013493
GenPept AAG15426 AAH13493

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca